AZIM-500 TAB
— Product

AZIM-500 TAB

AZITHROMYCIN 500MG

AZIM-500 TAB is a tablet of azithromycin 500 mg, a macrolide antibiotic. It is used for respiratory tract infections including sinusitis, bronchitis and community-acquired pneumonia, for skin and soft-tissue infections, and for certain sexually transmitted infections. This is the strength usually used for the standard three-day course or as the loading dose of a five-day course.

01

Benefits

  • Covers the atypical organisms — Mycoplasma, Chlamydia and Legionella — that beta-lactam antibiotics miss, alongside common respiratory pathogens.
  • A three-day course of one tablet daily provides roughly ten days of therapeutic tissue levels, because the drug persists in tissue long after dosing stops.
  • Short, once-daily courses substantially improve the likelihood that patients finish the treatment.
  • Concentrates within phagocytes, which carry the drug to the site of infection.
  • Effective as single-dose or short-course treatment in specific sexually transmitted infections, an advantage where follow-up is uncertain.
  • A useful option in penicillin-allergic patients.
02

Side effects

Not everyone gets these. Most are mild and settle as the course finishes.

Common
  • Nausea, abdominal pain or cramping
  • Diarrhoea or loose stools
  • Vomiting
  • Headache
Less common
  • Altered sense of taste
  • Raised liver enzymes on testing
  • Skin rash or itching
  • Vaginal or oral thrush following the course
Stop and get medical help if any of these occur
  • Severe, watery or bloody diarrhoea, during or in the weeks after the course
  • Yellowing of the skin or eyes, or dark urine
  • Palpitations, fainting, or an irregular heartbeat
  • Swelling of the face, lips or tongue, or difficulty breathing
  • Widespread rash with blistering or peeling skin
03

Precautions

  • Contraindicated in known hypersensitivity to azithromycin, erythromycin or any macrolide.
  • Azithromycin prolongs the QT interval. Avoid in congenital long QT syndrome, significant bradycardia or uncorrected electrolyte disturbance, and use with care alongside other QT-prolonging drugs.
  • Use with caution in significant hepatic impairment; stop if signs of liver dysfunction appear.
  • Correct low potassium or magnesium before starting.
  • Complete the full prescribed course even once symptoms settle, to limit the emergence of resistance.
  • Separate dosing from aluminium- or magnesium-containing antacids by at least two hours.
  • Use in pregnancy and breastfeeding only where clearly indicated.